1. Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems Shang, Enyuan; Zhang, Yiru; Shu, Chang; Ishida, Chiaki Tsuge; Bianchetti, Elena; Westhoff, Mike-Andrew; Karpel-Massler, Georg; Siegelin, Markus D. 2018 Articles Glioblastoma multiformeTumors--TreatmentNeurogliaCell deathCancer--Treatment
2. The effect of matrix stiffness, composition, and three-dimensionality on p53 expression in engineered human bone tumors Liu, Zen 2018 Theses Biomedical engineeringTissue engineeringOncologyp53 antioncogeneTumors--Treatment
3. Toward integrative cancer immunotherapy: targeting the tumor microenvironment Emens, Leisha A.; Silverstein, Samuel C.; Khleif, Samir; Marincola, Francesco M.; Galon, Jérôme 2012 Articles Tumors--TreatmentMedicine--ResearchCancer--ImmunotherapyMedicineBiochemistryOncology
4. Rapid in vivo Taxotere quantitative chemosensitivity response by 4.23 Tesla sodium MRI and histo-immunostaining features in N-Methyl-N-Nitrosourea induced breast tumors in rats Sharma, Rakesh; Kline, Richard P.; Wu, Ed X.; Katz, Jose 2005 Articles Tumors--TreatmentMagnetic resonance imagingDocetaxelCytologyOncologyMedicine